Kevin Biglan
| Title | Associate Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Neurology |
|---|
| Address | |
|---|
|
|
|
|
|
|
| 1988-1992 Walton Academic Scholar, Scholarship awarded to the top 10% of matriculating students
1991, 1992 Deans Achievement Award, Award given to junior and senior students for academic excellence
1992 Cyrus E. Beekey Memorial Award, Award to a graduating senior for excellence in biology.
1996 Arthur Krieger Memorial Prize in Neurology, Award to the senior medical student exhibiting excellence in neurology
2000 Alpha Omega Alpha, Medical honor society.
2000 American Academy of Neurology Resident Scholarship, Scholarship awarded to residents exhibiting dedication to teaching
2002,2004 NIH Clinical Research Loan Repayment Award, A competitive award for clinical researchers wishing to pursue a career in academic medicine |
-
Killoran A, Biglan KM. 8-OHdG: its (limited) potential as a biomarker for Huntington's disease. Biomark Med. 2012 Dec; 6(6):777-80.
-
Grana MJ, Bull MT, Venkataraman V, Dorsey ER, Biglan KM. Web-based clinical assessments for Parkinson's disease: Reliable and feasible. Mov Disord. 2012 Sep 15; 27(11):1466.
-
Shprecher D, Noyes K, Biglan K, Wang D, Dorsey ER, Kurlan R, Adams MJ. Willingness of Parkinson's disease patients to participate in research using internet-based technology. Telemed J E Health. 2012 Nov; 18(9):684-7.
-
Unschuld PG, Joel SE, Liu X, Shanahan M, Margolis RL, Biglan KM, Bassett SS, Schretlen DJ, Redgrave GW, van Zijl PC, Pekar JJ, Ross CA. Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease. Neurosci Lett. 2012 Apr 18; 514(2):204-9.
-
Dorsey R, Biglan K, Eberly S, Auinger P, Brocht A, Umeh CC, Oakes D, Clarence-Smith K, Marshall F, Shoulson I, Frank S. Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study. PLoS Curr. 2011; 3:RRN1283.
-
Vaccarino AL, Sills T, Anderson KE, Biglan K, Borowsky B, Giuliano J, Guttman M, Ho AK, Kennard C, Kupchak P, Landwehrmeyer GB, Michell A, Paulsen JS, Reilmann R, van Kammen DP, Warner JH, Evans K. Assessment of motor symptoms and functional impact in prodromal and early huntington disease. PLoS Curr. 2011; 2:RRN1244.
-
Dorsey ER, Deuel LM, Beck CA, Gardiner IF, Scoglio NJ, Scott JC, Marshall FJ, Biglan KM. Group patient visits for Parkinson disease: a randomized feasibility trial. Neurology. 2011 May 3; 76(18):1542-7.
-
Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH. Neurocognitive signs in prodromal Huntington disease. Neuropsychology. 2011 Jan; 25(1):1-14.
-
Biglan KM. Tapping in Huntington disease: a path forward to preventive therapies? Neurology. 2010 Dec 14; 75(24):2142-3.
-
Deuel LM, Chesire AM, Eason S, Como PG, Biglan KM. Reply: An exploration of the burden experienced by spousal caregivers of individuals with Parkinson's disease. Mov Disord. 2010 Oct 15; 25(13):2254-5.
-
Dorsey ER, Voss TS, Shprecher DR, Deuel LM, Beck CA, Gardiner IF, Coles MA, Burns RS, Marshall FJ, Biglan KM. A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups. Mov Disord. 2010 Oct 15; 25(13):2128-35.
-
Abhinav K, Marsh L, Crain B, Reich SG, Biglan K. Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature. Neurol Sci. 2011 Feb; 32(1):159-63.
-
Dorsey ER, Deuel LM, Voss TS, Finnigan K, George BP, Eason S, Miller D, Reminick JI, Appler A, Polanowicz J, Viti L, Smith S, Joseph A, Biglan KM. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov Disord. 2010 Aug 15; 25(11):1652-9.
-
Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS. Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov Disord. 2009 Sep 15; 24(12):1763-72.
-
Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Arch Neurol. 2009 Sep; 66(9):1099-104.
-
Biglan KM, Voss TS, Deuel LM, Miller D, Eason S, Fagnano M, George BP, Appler A, Polanowicz J, Viti L, Smith S, Joseph A, Dorsey ER. Telemedicine for the care of nursing home residents with Parkinson's disease. Mov Disord. 2009 May 15; 24(7):1073-6.
-
Marsh L, Biglan K, Gerstenhaber M, Williams JR. Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord. 2009 Jan 30; 24(2):277-82.
-
Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP. The relationship between CAG repeat length and clinical progression in Huntington's disease. Mov Disord. 2008 Jul 15; 23(9):1223-7.
-
Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry. 2008 Aug; 79(8):874-80.
-
Biglan KM, Holloway RG, McDermott MP, Richard IH. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology. 2007 Jul 10; 69(2):187-95.
-
Frank S, Biglan K. Long-term fetal cell transplant in Huntington disease: stayin' alive. Neurology. 2007 Jun 12; 68(24):2055-6.
-
Biglan K, Shoulson I. Juvenile-onset huntington disease: a matter of perspective. Arch Neurol. 2007 Jun; 64(6):783-4.
-
Biglan KM, Ravina B. Neuroprotection in Parkinson's disease: an elusive goal. Semin Neurol. 2007 Apr; 27(2):106-12.
-
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007 Jan 30; 68(5):384-6.
-
Biglan KM, Halmagyi M. The eyes as a window into disease prevention. Neurology. 2006 Aug 8; 67(3):376-7.
-
Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Mov Disord. 2006 May; 21(5):616-23.
-
Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53.
-
Biglan KM, Holloway RG. Surrogate endpoints in Parkinson's disease research. Curr Neurol Neurosci Rep. 2003 Jul; 3(4):314-20.
-
Young WB, Piovesan EJ, Biglan KM. Restless legs syndrome and drug-induced akathisia in headache patients. CNS Spectr. 2003 Jun; 8(6):450-6.
-
Biglan KM, Holloway RG. A review of pramipexole and its clinical utility in Parkinson's disease. Expert Opin Pharmacother. 2002 Feb; 3(2):197-210.
-
Biglan K, Holloway RG. Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials. Curr Neurol Neurosci Rep. 2001 Jul; 1(4):329-36.
|
Biglan's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
